While the broader biotech sector has seen high valuations, Novo's low multiples stand out. At 14 P/E and reasonable forward ratios, the stock offers a rare combination of value and durability, unlike ...

Norwegian Cruise Line trades for much lower revenue and forward earnings multiples than its peers. It has declined over the past year, a sharp contrast to the double-digit gains by It will have a lot ...